Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalMarket CapitalizationReturn on AssetsReturn on Capital EmployedReturn on Equity

Denali Therapeutics (DNLI) Debt to Equity: 2022

Historic Debt to Equity for Denali Therapeutics (DNLI) over the last 1 years, with Dec 2022 value amounting to $0.00.

  • Denali Therapeutics' Debt to Equity was N/A to $0.00 in Q4 2022 from the same period last year, while for Dec 2022 it was $0.00, marking a year-over-year change of. This contributed to the annual value of $0.00 for FY2022, which is N/A change from last year.
  • Denali Therapeutics' Debt to Equity amounted to $0.00 in Q4 2022, which was up 136.67% from $0.00 recorded in Q3 2022.
  • Over the past 5 years, Denali Therapeutics' Debt to Equity peaked at $0.00 during Q4 2022, and registered a low of $0.00 during Q3 2022.
  • For the 1-year period, Denali Therapeutics' Debt to Equity averaged around $0.00, with its median value being $0.00 (2022).